Besides providing the field with top sicencie research on biomarker discovery and new therapeutic targets, one additional aim of CIBBIM-Nanomedicine is to provide the Industry and other research groups wit an optimal in vitro and in vivo validation platforms for “proof of concep” demonstrations and initial preclinical studies of new nanotechnological based approaches. With this purpose, this area is formed by two technological platforms, one for in vitro analyses (In vitro Experimental Platform), and another one for those studies requiring animal experimentation (In vivo Experimental Platform).

The Area of “Functional Validation and Preclinical Research” aims to provide the industry and other research groups with an optimum technical platform for testing new biomedical applications based on the nanotechnology from compounds for the treatment of specific diseases to new applications in diagnosis and imaging. Likewise, the efficacy and toxicity of the therapeutic nanoconjugates developed in collaboration with other research groups and companies are being currently evaluated, with the objective of favouring the entry of those compounds into clinical trials.

The area is formed by two technological platforms, one for in vitro analyses (In vitro Experimental Platform), and another one for those studies requiring animal experimentation (In vivo Experimental Platform). Both platforms are partially financed by the CIBER-BBN (Biomedical Research Networking Center in Biomaterial, Bioingineering and Nanomedicine) and belong to the research infrastructure of CIBER- BBN. The Area of Functional Validation and Preclinical Studies also takes part in the Toxicological Experimental Platform of CIBER-BBN, a platform shared with the Institut de Recerca del Hospital de la Santa Creu i Sant Pau.

Downloadable Files

Note: You can click on right mouse button and click "Save Link As..." to save this file on your computer disk.

Funtional Validation & Preclinics (CIBBIM-Nanomedicine).pdf

CIBER-BBN Research Infrastructure on Biomedicine.pdf